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than in the pivotal study because the study was not long
enough to achieve better results. On the other hand, PFS was
higher than in the pivotal study which was 2.0 months.
Adverse effects confirmed haematologic toxicity.
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Background The involvement of a multidisciplinary team in
the management of a patient’s transfer from hospital to hospi-
tal has been shown to improve patient outcomes and reduce
readmissions. Hospital pharmacy discharge medicines review
aims to improve patient compliance and comprehension. NHS
Wales Informatics Service (NWIS) are considering whether
hospital pharmacists should be sent a copy of the discharge
advice letter (DAL).
Purpose The study aimed to evaluate and quantify the views
of the public on hospital pharmacist’s access to the patients’
DAL.
Material and methods A pre-piloted questionnaire was sent to
a total of 4000 participants across the whole of Wales. The
participants’ agreement was sought using a Likert scale, to
share information related to hospital admission details, hospital
discharge details, clinical information, medication information
and recommendations. Sampling clusters were identified based
on population size, and then categories were purposively
assigned to local authorities to obtain a representative sample
of the whole of Wales. Random sampling using Excel was
used to select participants from the edited electoral roll.
Quantitative data were analysed by SPSS 20 and qualitative
free text comments were analysed via inductive thematic
analysis.
Results 12.5% questionnaires were returned. The majority of
respondents either agreed or strongly agreed to all types of
hospital discharge information being shared with the hospital
pharmacist to increase patient safety; 30% preferred this infor-
mation to be shared electronically. Almost half of the public
(49.7%) felt that consent should explicitly be provided for
every hospital discharge. Five broad themes were identified,
each containing a number of sub-themes. These included per-
sonal details, relationship with hospital pharmacy, sharing
information with a hospital pharmacy, patient consent and
opinions of hospital pharmacists having access to hospital dis-
charge information. The study revealed a low usage of phar-
macy services and further education about the role of the
pharmacist should help to integrate the services with that of
other health professionals.
Conclusion The results will be fed back to NWIS for review
in the hope hospital pharmacists will gain access to DALs
which would be expected to improve patient care and poten-
tially save costs.
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Background Herbal medicines (HM) are those with active
ingredients made from plant parts, such as leaves, roots or
flowers. However, being ‘natural’ does not necessarily mean
they are safe to take.1 Taking HMs may not be suitable for
children: as for all medicines. The NHS recommends that
parents ask a paediatrician or pharmacist before giving a HM
to their children.1
Purpose To investigate HM use in the paediatric population
(0–18 years).
Material and methods We conducted a prospective study, using
a questionnaire delivered to parents waiting in a paediatric
practice office. Questions concerned: most used HMs, general
opinion about HMs and practical experience (as to their effi-
cacy and side effects).
Results 92 questionnaires have been collected to date. 90.2%
of those interviewed were mothers. 78.3% affirmed the use of
HMs for their children. HMs were mostly used for cough
and cold syndromes. 76.9% of mothers bought HMs less than
5 times a year. HMs were mostly suggested by the paediatri-
cian (49.2%) or pharmacist (47.7%), and less frequently by
the seller in the herbalist’s shop (10.8%) or by the natural
health practitioner (6.2%). 63.6% considered HMs use as an
alternative medicine, 50.6% as effective as conventional medi-
cine and 44.4% affirmed that the efficacy HMs depends on
the product. 83.8% considered HMs less dangerous than con-
ventional drugs. 84% of parents said that children did not
develop side effects after HM administration. The majority of
parents reported HM use to the doctor in the case of drug
prescription (45.1%); 68.4% were aware of interactions of
HMs with other substances.
Conclusion Even if this subject is relevant and our data show
that HMs are frequently used in children, overall information
are lacking in the literature. Hence one of our purposes
would be to implement our study, extending it to a more
widespread population.
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